Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5562 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 53 54 55 56  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Helmholtz–Carl Zeiss: MIRAX Virtual Slide Scanner, –200905– supply existent use of product at Helmholtz Centre Munich 2009-05-28
Evotec–Promega: HaloTag technology, 200905 supply use existent by Evotec in drug screening 2009-05-27
mtm Laboratories–MetaSystems: Metafer system, 200905– collab co-developm customised automated imaging system for CINtec Cytology products 2009-05-26
Max Planck–Inventive Capital: financial services, 200905 service development of DDC Ventures fund by MP Innovation + Inventive Capital Advisors LLP 2009-05-14
Max Planck–Life Sciences Partners: financial services, 200905– service management of DDC Ventures fund by LSP 2009-05-14
ExcellGene–Adolf Kühner: OrbShake bioreactor, –200905– collab existent development 2009-05-12
Panatecs–CovalX: mass spectrometry, 200905– supply Panatecs to offer MALDI-TOF proteomic services using High-Mass System from CovalX 2009-05-08
Renovis–Evotec: investment, 200905 DIVESTMENT shut down of Renovis + Evotec US operations 2009-05-05
Double-CISH-LCD-Array project–Germany (govt): grant, 200905–201204 grant €644k KMU-Innovativ-3 programme from BMBF 2009-05-01
ZytoVision–Germany (govt): grant, 200905–201204 grant €247k to ZytoVision GmbH in Double-CISH-LCD-Array project from BMBF 2009-05-01
Fresenius–Trion Pharma: catumaxomab, 200712 collab existent drug registration + marketing of Removab by Fresenius Biotech 2009-04-23
Miacom Diagnostics–Inveni Capital: investment, 200904 investment by Inveni Capital 2009-04-17
Exiqon–Tecan: HS 800 Pro Hybridization Station, –200904– supply existent use to develop miRCURY LNA assays for CUP 2009-04-15
British American Tobacco–Tecan: Freedom EVO platform, –200904– supply use existent by ATC for QPCR to assay transgenic plant cells 2009-04-14
Henniker Scientific–InProcess Instruments: mass spectrometer, 200904– distribution and service in GB by Henniker Scientific Ltd. 2009-04-11
Henniker Scientific–InProcess Instruments: mass spectrometer, 200904– distribution and service in Ireland by Henniker Scientific Ltd. 2009-04-11
Bruker Corp–CMS: legal services, 200904 service legal advice by CMS Hasche Sigle on acqu of ACCEL Instruments by Bruker Advanced Supercon 2009-04-03
Finnzymes–Roche: Melting Curve Analysis technology, 200904– license melting curve analysis + SYBR Green I techn for real-time PCR from Idaho + Roche 2009-04-03
Idaho Technology–Roche: PCR technology, 200904 collab existent programme to license IP incl SYBR Green I + Melting Curve Analysis technologies 2009-04-03
Quanterix–Tecan: Freedom EVO platform, –200904– supply use existent for developm of SiMoA technology 2009-04-02
Sony–iCyt: flow cytometry, 200904– collab development of new flow cytometry device 2009-04-01
Mologen–SEVERAL: investment, 200903 capital increase €2.8m 425k new shares €6.5/share to institutional investors 2009-03-27
Panatecs–Germany (govt): investment, 200903 financing round totalling €5m KfW Mittelstandsbank + Zukunftsfonds Heilbronn 2009-03-26
Panatecs–SEVERAL: investment, 200903 financing round €5m KfW Mittelstandsbank + Zukunftsfonds Heilbronn 2009-03-26
Panatecs–Zukunftsfonds Heilbronn: investment, 200903 financing round totalling €5m KfW Mittelstandsbank + Zukunftsfonds Heilbronn 2009-03-26
DxS–Roche: LightCycler Adapt Software, 200903– license €na for use w TheraScreen: K-RAS Mutation Kits on LightCycler 480 Instrument II 2009-03-23
Kompass–Ribocon: SepsiTest BLAST tool, –200903 collab service developm SepsiTest BLAST tool for Molzym’s SepsiTest 2009-03-20
Helmholtz–Tecan: lab automation equipment, 200903 supply existent use of HydroFlex washer + Infinite 200 reader w Connect stacker at DKFZ 2009-03-16
Biokatalyse2021 Cluster–SeSaM-Biotech: industrial biotechnology, 200903– collab SeSaM becomes project partner of Biokatalyse2021 2009-03-15
Imaging Service–Definiens: LymphExpert software, 200903– supply use of LymphExpert in analysis of patient CT images by Imaging Service AG 2009-03-07
Atheso Arzneimittelsicherheit–NONE: investment, 200903–201007 bankruptcy Local Court Hanover IN 187/09 2009-03-03
READNA project–Febit: HybSelect technology, 200903– participant Febit joins READNA consortium 2009-03-03
Anagnostics–Niederösterreich (govt): investment, 200902 financing round totalling €3m incl VC equity from tecnet equity 2009-02-27
Anagnostics–SEVERAL: investment, 200902 financing round €3m incl VC equity from tecnet equity + PP Capital + credit from ASO 2009-02-27
Millipore–Epitome Biosystems: EpiTag technology, 200902 acquisition €na of EpiTag technology associated assets by Millipore 2009-02-26
Funakoshi–Caprotec: CCMS technology, 200902– distribution excl of Caprotec products in Japan by Funakoshi Co Ltd 2009-02-09
Microstim–High-Tech Gründerfonds: investment, 200902 investment €500k by HTGF 2009-02-05
Boehringer–Cenix BioScience: drug discovery services, 200902– collab research HT applications of RNAi-based gene silencing for drug target discovery 2009-02-02
Tufts Univ–Bruker Corp: mass spectrometer, 200902 supply Microflex MALDI-TOF installed at Dept of Chemistry 2009-02-01
Nanonis–SPECS (DE): investment, 200901 acquisition Nanonis to be renamed SPECS Zurich GmbH 2009-01-30
AC Immune–SEVERAL: investment, 200901 financing round Series C CHF40m from existing investors 2009-01-26
HiperScan–High-Tech Gründerfonds: investment, 200901 equity investment €500k by HTGF 2009-01-19
Merck (DE)–Apitope: ATX-MS-1467, 200901– license excl ww developm + commercialisation to Merck Serono 2009-01-13
Bayer–Performance Plants: YPT technology, 2009– license research + commercial for use in cotton for Bayer CropScience 2009-01-01
Bayer–Tsinghua Univ: drug discovery, 2009– collab establishment of Bayer-Tsinghua Joint Research Center for Innovative Drug Discovery 2009-01-01
BMS–Qiagen: molecular companion diagnostics, 2009– collab incl therascreen KRAS RGQ PCR Kit for Erbitux 2009-01-01
Bruker Corp–Germany (govt): grant, 200901–201208 grant €364k to Bruker Daltonik GmbH in SysTec project from BMBF 2009-01-01
CNIO–Bruker Corp: mass spectrometer, 2009 supply installation Maxis QQTOF equipped w nanoflow UPLC system at Proteomics Core Unit 2009-01-01
DOT-MOBI project–Germany (govt): grant, 200901–201112 grant as Verbundprojekt from BMBF coordindator MeVis Medical Solutions AG 2009-01-01
DOT-MOBI project–MeVis: molecular imaging, 200901–201112 collab MeVis Medical Solutions project coordinator + developm s/w platform oncologic imaging 2009-01-01
EndoSense–LCF Rothschild: investment, 2009 investment in EndoSense by Edmond de Rothschild Investment Partners 2009-01-01
FORTH–Thermo Fisher: mass spectrometer, 2009 supply purchase LTQ-Orbitrap XL with ETD by Proteomics Facility of IMBB-FORTH 2009-01-01
GeneBio–Swiss Institute of Bioinformatics: neXtProt knowledge platform, 20090– collab development 2009-01-01
GlycoVaxyn–LCF Rothschild: investment, 2009 investment in GlycoVaxyn by Edmond de Rothschild Investment Partners 2009-01-01
Jacobs Univ–Germany (govt): grant, 200901–201012 grant €231k to School of Engineering and Science from BMBF KMU Innovativ BioChance 2009-01-01
JnJ–Cenix BioScience: siRNA technology, 2009– collab improvement of siRNA-based target validation methodologies Janssen Pharmaceutica NV 2009-01-01
Kolltan–Celtic Therapeutics: investment, 2009 acquisition of minority share in Kolltan Pharmaceuticals Inc 2009-01-01
Merck (DE)–Compugen: biomarker, 2009 collab discovery of biomarker signatures for drug induced toxicity Merck Serono 2009-01-01
Merck (DE)–Compugen: biomarker, 201206 collab founding joint venture Neviah Genomics with funding from Merck + technology from Compugen 2009-01-01
MeVis–Germany (govt): grant, 200901–201112 grant €880k for MeVis Medical Solutions AG for Verbundprojekt DOT-MOBI from BMBF 2009-01-01
Novartis–Nuevolution: drug discovery services, 2009– service using Chemetics technology to discover compounds against Novartis targets 2009-01-01
Novartis–Nuevolution: drug discovery technology, 201401– collab + non-excl licencse €na for using Chemetics technology with + within Novartis 2009-01-01
Spirogen–Celtic Therapeutics: investment, 2009 acquisition of majority share in Spirogen Ltd 2009-01-01
SysTec project–Bruker Corp: systems biology, 200901–201208 collab Bruker Daltonik project partner for proteomic MALDI imaging 2009-01-01
SysTec project–Germany (govt): grant, 2009– grant for systems biology research programme from BMBF 2009-01-01
Univ Bremen–Germany (govt): grant, 200901–201012 grant €255k from BMBF for UniTransfer Transferstelle 2009-01-01
Viollier–Bruker Corp: mass spectrometer, 2009 supply + agreement for use of MALDI Biotyper 2009-01-01
European Biotechnology Foundation–Biocom: investment, –200812–200912– existent Biocom AG owns 100% of EFB 2008-12-31
MeVis–PERSON: investment, 200812 existent 12/08 Carl JG Evertsz owns 354,640 shares = 19.49% = €14.9m 2008-12-31
MeVis–PERSON: investment, 200812 existent 12/08 Heinz-Otto Peitgen owns 354,039 shares = 19.45% = €14.9m 2008-12-31
MeVis–PERSON: investment, 200812 existent 12/08 Olaf Sieker + his wife own 53,122 shares = 3% = €2.2m 2008-12-31
Surgipath–Danaher: investment, 200812 acquisition of Surgipath Medical Industries Inc by Leica Microsystems 2008-12-30
Curetis–Aeris Capital: investment, 200812 seed financing €1.4m 2008-12-18
MeVis–Performaxx: analyst coverage, 200812–200909–existent analyst Adam Jakubowski 2008-12-17
Caprotec–Berlin (govt): grant, 200812– grant €0.6m 2y for RnD of Capture Compounds + caproKits from State of Berlin + ERDF/EFRE 2008-12-15
Phytolutions–Bremen (govt): grant, 200812–201012 grant €250k for pilot project algae biofuel production from WFB Bremen within PFAU programme 2008-12-15
Danaher–MDS: MetaMorph software, –200812– collab existent integration Metamorph s/w with Leica imaging systems 2008-12-05
Max Planck–Proxeon: EASY-nLC, 200811 supply MPI for Biochemisty Mann Group to standardise LC/MS on EASY-nLC 2008-11-11
Helsinn–Zealand Pharma: GLP-2 peptide agonist, 200811–201706 license ww excl to elsiglutide €140m milestones + royalties RIGHTS RETURNED 6/17 2008-11-01
Millipore–Applikon: disposable bioreactor, 200811– collab development CellReady 3L Bioreactor 2008-11-01
Phenex–SEVERAL: investment, 200810 financing round €8.2m lead investor LBBW Venture 2008-10-02
Axicorp–Biocon: investment, 200810 acquisition 70% for €30m 2008-10-01
Jacobs Univ–Germany (govt): grant, 200810–201109 grant €172.6k from BMBF for project within Biokatalyse2021 Cluster 2008-10-01
Kirin–Kyowa Hakko Kogyo: investment, 200810 merger of Kirin Pharma + Kyowa Hakko Kogyo into Kyowa Hakko Kirin 2008-10-01
Kompass–Germany (govt): grant, 200810–201109 grant €193.2k from BMBF for Molzym GmbH & Co KG within Biokatalyse2021 Cluster 2008-10-01
Kompass–Jacobs Univ: white biotechnology, 200810–201109 collab within Biokatalyse2021 Cluster developm nucleases + proteases for pre-analytics 2008-10-01
Univ Applied Sciences Bremen–Bremen (govt): grant, 200810–201109 grant €68k for developm nucleases for molecular analytics WFB RnD Innovation Progr 2008-10-01
Telormedix–College Group: public relations, 200809–201109– service existent by College Hill Life Sciences 2008-09-30
Telormedix–SEVERAL: investment, 200809 financing round Series A CHF21m=€13.1m=$19m led by Aravis Venture 2008-09-30
Direvo Industrial Biotechnology–TVM: investment, 200809 financing round Series A totalling €8m incl co-investor TVM Capital 2008-09-16
Ciba Spezialitätenchemie–BASF: investment, 200809–200904 acquisition 2008-09-01
Merck (DE)–Ablynx: Nanobodies, 200809– collab co-discovery + co-developm Nanobodies against two targets in immunology + oncology Merck Serono 2008-09-01
Allianz–Commerzbank: investment, 200808– acquisition €9.8b of Dresdner Bank AG by Commerzbank AG 2008-08-31
Denali Therapeutics–Evotec: CNS drug discovery, 201608 strategic collab existent 2008-08-25
Denali Therapeutics–Roche: LRRK2 inhibitors, 201608 license ww excl existent to develop + commericalize LRRK2 inhibitors from Genentech 2008-08-25
MeVis–LBBW: analyst coverage, 200808–200902 analyst Michael Busse 2008-08-22
S.I.S. Surface Imaging Systems–Bruker Corp: investment, 200808 acquisition €na by Bruker AXS to be renamed Bruker Nano GmbH 2008-08-18
Univ Applied Sciences Bremen–Germany (govt): grant, 200808–201107 grant €183k from BMBF for ProTool project within Biokatalyse2021 Cluster 2008-08-01
ZytoVision–Germany (govt): grant, 200808–201107 grant €138.4k from BMBF for ProTool project within Biokatalyse2021 Cluster 2008-08-01
Novartis–Cytos Biotechnology: Alzheimer vaccine, 200807 collab existent for CAD106 2008-07-24
next pagenext page 1 2 3 ... 53 54 55 56  next pagenext page



Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top